California Public Employees Retirement System Cuts Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

California Public Employees Retirement System lowered its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 2.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 359,807 shares of the company’s stock after selling 8,575 shares during the quarter. California Public Employees Retirement System’s holdings in Acadia Healthcare were worth $27,979,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of ACHC. Headlands Technologies LLC bought a new stake in Acadia Healthcare in the third quarter valued at approximately $25,000. Fifth Third Bancorp lifted its position in Acadia Healthcare by 25.5% in the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after purchasing an additional 136 shares during the last quarter. DekaBank Deutsche Girozentrale bought a new stake in Acadia Healthcare in the third quarter valued at approximately $96,000. Oak Thistle LLC bought a new position in shares of Acadia Healthcare during the fourth quarter valued at approximately $235,000. Finally, Advisor Partners II LLC raised its holdings in shares of Acadia Healthcare by 7.5% during the third quarter. Advisor Partners II LLC now owns 3,351 shares of the company’s stock valued at $236,000 after acquiring an additional 234 shares in the last quarter.

Analyst Ratings Changes

ACHC has been the subject of a number of recent analyst reports. TD Cowen upped their target price on Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Stephens upgraded Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 target price for the company in a report on Friday, January 5th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price for the company in a report on Thursday. UBS Group increased their price objective on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a report on Monday, March 4th. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $92.00.

Acadia Healthcare Stock Up 0.3 %

NASDAQ ACHC opened at $73.59 on Friday. The stock’s 50-day moving average price is $78.07 and its 200-day moving average price is $77.70. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48. Acadia Healthcare Company, Inc. has a 52 week low of $66.49 and a 52 week high of $87.77. The company has a market capitalization of $6.80 billion, a P/E ratio of -294.35, a price-to-earnings-growth ratio of 2.17 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.80 by $0.05. The firm had revenue of $742.80 million for the quarter, compared to the consensus estimate of $727.60 million. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.70 earnings per share. On average, equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current year.

Insider Activity at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.80% of the stock is owned by corporate insiders.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.